Sec Form 4 Filing - Blaser Brian J @ ABBOTT LABORATORIES - 2012-12-06

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Blaser Brian J 2. Issuer Name and Ticker or Trading Symbol ABBOTT LABORATORIES [ ABT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Executive Vice President (Last) (First) (Middle) 100 ABBOTT PARK ROAD 3. Date of Earliest Transaction (MM/DD/YY) 12/06/2012 (Street) ABBOTT PARK, IL60064 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common shares without par value 12/06/2012 M 3,000 A $ 46.34 82,724 D Common shares without par value 12/06/2012 M 3,800 A $ 44.16 86,524 D Common shares without par value 12/06/2012 M 5,700 A $ 53.6 92,224 D Common shares without par value 12/06/2012 M 5,800 A $ 55.56 98,024 D Common shares without par value 12/06/2012 M 12,800 A $ 54.14 110,824 D Common shares without par value 12/06/2012 M 6,467 A $ 54.5 117,291 D Common shares without par value 12/06/2012 M 12,667 A $ 48.34 129,958 D Common shares without par value 12/06/2012 M 13,867 A $ 46.6 143,825 D Common shares without par value 12/06/2012 S 1,300 D $ 64.405 142,525 D Common shares without par value 12/06/2012 S 400 D $ 64.415 142,125 D Common shares without par value 12/06/2012 S 100 D $ 64.4175 142,025 D Common shares without par value 12/06/2012 S 2,100 D $ 64.42 139,925 D Common shares without par value 12/06/2012 S 1,300 D $ 64.425 138,625 D Common shares without par value 12/06/2012 S 100 D $ 64.4275 138,525 D Common shares without par value 12/06/2012 S 2,200 D $ 64.43 136,325 D Common shares without par value 12/06/2012 S 1,600 D $ 64.435 134,725 D Common shares without par value 12/06/2012 S 3,900 D $ 64.44 130,825 D Common shares without par value 12/06/2012 S 1,700 D $ 64.445 129,125 D Common shares without par value 12/06/2012 S 100 D $ 64.4475 129,025 D Common shares without par value 12/06/2012 S 100 D $ 64.449 128,925 D Common shares without par value 12/06/2012 S 3,800 D $ 64.45 125,125 D Common shares without par value 12/06/2012 S 1,300 D $ 64.455 123,825 D Common shares without par value 12/06/2012 S 2,100 D $ 64.46 121,725 D Common shares without par value 12/06/2012 S 500 D $ 64.465 121,225 D Common shares without par value 12/06/2012 S 200 D $ 64.4675 121,025 D Common shares without par value 12/06/2012 S 4,600 D $ 64.47 116,425 D Common shares without par value 12/06/2012 S 3,900 D $ 64.475 112,525 D Common shares without par value 12/06/2012 S 100 D $ 64.4775 112,425 D Common shares without par value 12/06/2012 S 5,247 D $ 64.48 107,178 D Common shares without par value 12/06/2012 S 1,100 D $ 64.485 106,078 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Option (right to buy) ( 1 ) $ 46.34 12/06/2012 M 3,000 02/18/2008 02/17/2015 Common shares 3,000 $ 0 0 D Option (right to buy) ( 1 ) $ 44.16 12/06/2012 M 3,800 02/17/2009 02/16/2016 Common shares 3,800 $ 0 0 D Option (right to buy) ( 1 ) $ 53.6 12/06/2012 M 5,700 07/20/2010 07/19/2017 Common shares 5,700 $ 0 0 D Option (right to buy) ( 1 ) $ 55.56 12/06/2012 M 5,800 02/15/2011 02/14/2018 Common shares 5,800 $ 0 0 D Option (right to buy) ( 1 ) $ 54.14 12/06/2012 M 12,800 02/20/2012 02/19/2019 Common shares 12,800 $ 0 0 D Option (right to buy) ( 2 ) $ 54.5 12/06/2012 M 6,467 02/19/2012 02/18/2020 Common shares 6,467 $ 0 3,233 D Option (right to buy) ( 2 ) $ 48.34 12/06/2012 M 12,667 05/17/2012 05/16/2020 Common shares 12,667 $ 0 6,333 D Option (right to buy) ( 2 ) $ 46.6 12/06/2012 M 13,867 02/18/2012 02/17/2021 Common shares 13,867 $ 0 27,733 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Blaser Brian J 100 ABBOTT PARK ROAD ABBOTT PARK, IL60064 Executive Vice President Signatures John A. Berry, by power of attorney for Brian J. Blaser 12/10/2012 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. ( 2 )Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks: Form 1 of 2.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.